Literature DB >> 3514747

Potassium supplementation in blacks with mild to moderate essential hypertension.

S M Matlou, C G Isles, A Higgs, F J Milne, G D Murray, E Schultz, I F Starke.   

Abstract

Potassium chloride (KCl) salt (65 mmol) daily reduced BP from 153/104 to 146/101 mmHg in 32 hypertensive black females during a 6-week placebo controlled crossover study. The fall in BP was independent of the order of randomization and was significant for systolic (SBP; P less than 0.01) and diastolic (DBP; P less than 0.05) pressure after 4 weeks. Analysis of the 95% confidence intervals in this and in five other studies, two of which were reported as showing no beneficial effect, suggests that potassium supplementation does lower BP, but that the change is small and within the confidence levels of all six trials. Thus, apparent discrepancies in the literature are not genuine statistically.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3514747     DOI: 10.1097/00004872-198602000-00010

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  11 in total

Review 1.  Management of hypertension in ethnic minorities.

Authors:  Jawad M Khan; D Gareth Beevers
Journal:  Heart       Date:  2005-08       Impact factor: 5.994

Review 2.  Recommendations of the Canadian Consensus Conference on Non-Pharmacological Approaches to the Management of High Blood Pressure, Mar. 21-23, 1989, Halifax, Nova Scotia.

Authors:  A Chockalingam; D Abbott; M Bass; R Battista; R Cameron; J de Champlain; C E Evans; J Laidlaw; B L Lee; L Leiter
Journal:  CMAJ       Date:  1990-06-15       Impact factor: 8.262

3.  Controlled trial of long term oral potassium supplements in patients with mild hypertension.

Authors:  A Siani; P Strazzullo; L Russo; S Guglielmi; L Iacoviello; L A Ferrara; M Mancini
Journal:  Br Med J (Clin Res Ed)       Date:  1987-06-06

4.  Lifestyle modifications to prevent and control hypertension. 6. Recommendations on potassium, magnesium and calcium. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.

Authors:  E Burgess; R Lewanczuk; P Bolli; A Chockalingam; H Cutler; G Taylor; P Hamet
Journal:  CMAJ       Date:  1999-05-04       Impact factor: 8.262

Review 5.  Non-pharmacological aspects of blood pressure management: what are the data?

Authors:  S Susan Hedayati; Essam F Elsayed; Robert F Reilly
Journal:  Kidney Int       Date:  2011-03-09       Impact factor: 10.612

Review 6.  Potassium and calcium intake, excretion, and homeostasis in blacks, and their relation to blood pressure.

Authors:  H G Langford; R L Watson
Journal:  Cardiovasc Drugs Ther       Date:  1990-03       Impact factor: 3.727

Review 7.  Replacing salt with low-sodium salt substitutes (LSSS) for cardiovascular health in adults, children and pregnant women.

Authors:  Amanda Brand; Marianne E Visser; Anel Schoonees; Celeste E Naude
Journal:  Cochrane Database Syst Rev       Date:  2022-08-10

8.  Salt Use Behaviours of Ghanaians and South Africans: A Comparative Study of Knowledge, Attitudes and Practices.

Authors:  Elias Menyanu; Karen E Charlton; Lisa J Ware; Joanna Russell; Richard Biritwum; Paul Kowal
Journal:  Nutrients       Date:  2017-08-28       Impact factor: 5.717

9.  Effects of Resistance Exercise and Nutritional Supplementation on Dynamic Cerebral Autoregulation in Head-Down Bed Rest.

Authors:  Marc Kermorgant; Nathalie Nasr; Marc-Antoine Custaud; Nastassia Navasiolava; Philippe Arbeille; Patrick Guinet; Marc Labrunée; Florent Besnier; Dina N Arvanitis; Marek Czosnyka; Jean-Michel Senard; Anne Pavy-Le Traon
Journal:  Front Physiol       Date:  2019-08-27       Impact factor: 4.566

Review 10.  Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses.

Authors:  Nancy J Aburto; Sara Hanson; Hialy Gutierrez; Lee Hooper; Paul Elliott; Francesco P Cappuccio
Journal:  BMJ       Date:  2013-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.